Clinical Trial Update: Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating candesartan cilexetil (Atacand) versus placebo after kidney biopsy in individuals with Type 1 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Type

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Diabetes, Type I | Phase 4 | Status: UNKNOWN